2025
SJR Q2
JCR Q2 · 3,1
128 eşleşen makale
SCIE
Dergi ayrıntısı
Journal of Microencapsulation
- Yayıncı
- Taylor and Francis Ltd.
- Ülke
- United Kingdom · Western Europe
- Tür
- journal
- ISSN
-
0265204814645246
Bütünleşik değerlendirme
Scopus tarafı Scimago SJR; WoS tarafı Master Journal List + JCR/JIF. Kaynaklar ISSN üzerinden eşleştirilir. WoS / JCR metrikleri yalnızca 1997 ve sonrası yıllar için vardır.
WoS / JCR verileri 1997 ve sonrası içindir.
Scopus
Scopus · Scimago
- SJR 0,502
- Quartile Q2
- H-Index 95
- Atıf/yayın 3,59
- Doküman (3y) 141
- Atıf (3y) 528
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,1
- 5Y JIF 3,4
- JCI 0,6
WoS indeksleri
- SCIE
Konu sınıflandırması
Kategoriler (SJR)
- Bioengineering Q3
- Colloid and Surface Chemistry Q3
- Organic Chemistry Q2
- Pharmaceutical Science Q2
- Physical and Theoretical Chemistry Q2
Alanlar
- Chemical Engineering
- Chemistry
- Pharmacology, Toxicology and Pharmaceutics
WoS kategorileri
- Chemistry, Applied | Engineering, Chemical | Pharmacology & Pharmacy
Yıllık quartile karşılaştırması
Scimago (SJR) tüm yıllar; Clarivate (JCR / JIF / JCI) 1997 ve sonrası. Güncel yıl açık; diğer yıllar kapalıdır.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,502 | 3,1 | 3,4 | 0,6 | Q2 | 95 |
| 2024 | Q2 | Q2 | 0,507 | 3,2 | 3,6 | 0,64 | Q2 | 91 |
| 2023 | Q2 | Q2 | 0,511 | 3 | 4,2 | 0,68 | Q2 | 91 |
| 2022 | Q2 | Q2 | 0,511 | 3,9 | 3,7 | 0,71 | Q2 | 91 |
| 2021 | Q2 | Q2 | 0,57 | 4 | 3,7 | 0,71 | Q2 | 91 |
| 2020 | Q2 | Q2 | 0,517 | 3,1 | 2,9 | 0,63 | Q2 | 91 |
| 2019 | Q2 | Q2 | 0,457 | 2,3 | 2,1 | 0,6 | Q2 | 91 |
| 2018 | — | Q2 | — | 2 | 1,9 | 0,52 | Q2 | — |
| 2017 | Q2 | Q2 | 0,52 | 1,8 | 1,9 | 0,52 | Q2 | 91 |
| 2016 | Q2 | Q3 | 0,476 | 1,5 | 1,8 | — | — | 91 |
| 2015 | Q2 | Q2 | 0,515 | 1,6 | 1,9 | — | — | 91 |
| 2014 | Q2 | Q2 | 0,574 | 1,6 | 1,7 | — | — | 91 |
| 2013 | Q1 | Q2 | 0,632 | 1,9 | 1,9 | — | — | 91 |
| 2012 | Q1 | Q2 | 0,696 | 1,6 | 1,8 | — | — | 91 |
| 2011 | Q2 | Q2 | 0,538 | 1,6 | 1,8 | — | — | 91 |
| 2010 | Q2 | Q2 | 0,504 | 1,5 | 1,7 | — | — | 91 |
| 2009 | — | Q1 | — | 1,9 | 1,9 | — | — | — |
| 2008 | — | Q2 | — | 1,3 | 1,9 | — | — | — |
| 2007 | — | Q2 | — | 1,2 | 1,4 | — | — | — |
| 2006 | — | Q2 | — | 0,8 | — | — | — | — |
| 2005 | — | Q1 | — | 1,4 | — | — | — | — |
| 2004 | — | Q1 | — | 1,5 | — | — | — | — |
| 2003 | — | Q2 | — | 0,9 | — | — | — | — |
| 2002 | — | Q1 | — | 1 | — | — | — | — |
| 2001 | — | Q1 | — | 1 | — | — | — | — |
| 2000 | — | Q1 | — | 1,1 | — | — | — | — |
| 1999 | — | Q1 | — | 1 | — | — | — | — |
| 1998 | — | Q1 | — | 0,8 | — | — | — | — |
| 1997 | — | Q1 | — | 0,8 | — | — | — | — |
JCR kategori quartile geçmişi
Yıla ve kategoriye göre JCR / JCI quartile. 1997 ve sonrası.
WoS / JCR verileri 1997 ve sonrası içindir.
| Yıl | Kategori | Edition | JCR Q (1997+) | JCI Q (1997+) | Sıra |
|---|---|---|---|---|---|
| 2025 | CHEMISTRY, APPLIED | SCIE | Q2 | Q2 | 35/77 |
| 2025 | ENGINEERING, CHEMICAL | SCIE | Q3 | Q2 | 101/183 |
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 163/356 |
| 2024 | CHEMISTRY, APPLIED | SCIE | Q2 | Q2 | 28/76 |
| 2024 | ENGINEERING, CHEMICAL | SCIE | Q2 | Q2 | 81/176 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q3 | 126/352 |
| 2023 | CHEMISTRY, APPLIED | SCIE | Q2 | Q2 | 29/74 |
| 2023 | ENGINEERING, CHEMICAL | SCIE | Q2 | Q2 | 74/170 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 136/354 |
| 2022 | CHEMISTRY, APPLIED | SCIE | Q2 | Q2 | 22/73 |
| 2022 | ENGINEERING, CHEMICAL | SCIE | Q2 | Q2 | 53/142 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 102/278 |
| 2021 | CHEMISTRY, APPLIED | SCIE | Q2 | Q2 | 24/73 |
| 2021 | ENGINEERING, CHEMICAL | SCIE | Q2 | Q2 | 58/143 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 113/279 |
| 2020 | CHEMISTRY, APPLIED | SCIE | Q2 | Q2 | 27/74 |
| 2020 | ENGINEERING, CHEMICAL | SCIE | Q2 | Q2 | 66/143 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 155/276 |
| 2019 | CHEMISTRY, APPLIED | SCIE | Q2 | Q2 | 28/71 |
| 2019 | ENGINEERING, CHEMICAL | SCIE | Q3 | Q2 | 73/143 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 173/271 |
| 2018 | CHEMISTRY, APPLIED | SCIE | Q2 | Q2 | 28/71 |
| 2018 | ENGINEERING, CHEMICAL | SCIE | Q2 | Q2 | 67/138 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 179/267 |
| 2017 | CHEMISTRY, APPLIED | SCIE | Q2 | Q2 | 35/72 |
| 2017 | ENGINEERING, CHEMICAL | SCIE | Q2 | Q2 | 67/137 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q3 | 195/261 |
| 2016 | CHEMISTRY, APPLIED | SCIE | Q3 | — | 37/72 |
| 2016 | ENGINEERING, CHEMICAL | SCIE | Q3 | — | 71/135 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 198/257 |
| 2015 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 31/72 |
| 2015 | ENGINEERING, CHEMICAL | SCIE | Q2 | — | 63/135 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 181/255 |
| 2014 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 31/72 |
| 2014 | ENGINEERING, CHEMICAL | SCIE | Q2 | — | 60/135 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 177/255 |
| 2013 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 26/71 |
| 2013 | ENGINEERING, CHEMICAL | SCIE | Q2 | — | 46/133 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 156/256 |
| 2012 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 28/71 |
| 2012 | ENGINEERING, CHEMICAL | SCIE | Q2 | — | 46/133 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 174/261 |
| 2011 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 25/71 |
| 2011 | ENGINEERING, CHEMICAL | SCIE | Q2 | — | 52/133 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 178/261 |
| 2010 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 26/70 |
| 2010 | ENGINEERING, CHEMICAL | SCIE | Q2 | — | 46/135 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 176/252 |
| 2009 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 21/64 |
| 2009 | ENGINEERING, CHEMICAL | SCIE | Q1 | — | 31/128 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 145/237 |
| 2008 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 27/61 |
| 2008 | ENGINEERING, CHEMICAL | SCIE | Q2 | — | 38/116 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 163/219 |
| 2007 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 26/62 |
| 2007 | ENGINEERING, CHEMICAL | SCIE | Q2 | — | 35/114 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 156/205 |
| 2006 | CHEMISTRY, APPLIED | SCIE | Q3 | — | 31/58 |
| 2006 | ENGINEERING, CHEMICAL | SCIE | Q2 | — | 51/110 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 170/199 |
| 2005 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 19/59 |
| 2005 | ENGINEERING, CHEMICAL | SCIE | Q1 | — | 27/116 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 127/193 |
| 2004 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 15/58 |
| 2004 | ENGINEERING, CHEMICAL | SCIE | Q1 | — | 16/116 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 110/187 |
| 2003 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 25/57 |
| 2003 | ENGINEERING, CHEMICAL | SCIE | Q2 | — | 37/119 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 138/185 |
| 2002 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 22/59 |
| 2002 | ENGINEERING, CHEMICAL | SCIE | Q1 | — | 22/126 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 129/188 |
| 2001 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 23/58 |
| 2001 | ENGINEERING, CHEMICAL | SCIE | Q1 | — | 26/123 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 124/186 |
| 2000 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 18/55 |
| 2000 | ENGINEERING, CHEMICAL | SCIE | Q1 | — | 15/117 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 111/181 |
| 1999 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 16/49 |
| 1999 | ENGINEERING, CHEMICAL | SCIE | Q1 | — | 21/110 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 103/175 |
| 1998 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 19/47 |
| 1998 | ENGINEERING, CHEMICAL | SCIE | Q1 | — | 22/113 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 107/178 |
| 1997 | CHEMISTRY, APPLIED | SCIE | Q2 | — | 21/44 |
| 1997 | ENGINEERING, CHEMICAL | SCIE | Q1 | — | 26/105 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 108/157 |